Patent · US Active

Compounds which modulate the CB2 receptor

US9315454B2 · kind B2 · utility

0Cited by

50References

12Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Alessandra Bartolozzi · Norwalk, US
Angela Berry · Gaylordsville, US
Doris Riether · Biberach an der Riß, DE
Monika Ermann · Wantage, GB
James Edward Jenkins · Hungerford, GB
Innocent Mushi · Felton, GB

Key dates

Filing date	Jan 11, 2011
Grant date	Apr 19, 2016
Priority date	—
Expiry date	Oct 28, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.